These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33387281)

  • 1. Test-retest reproducibility of dopamine transporter density measured with [
    Son HJ; Oh JS; Oh M; Lee SJ; Oh SJ; Chung SJ; Kim JS
    Ann Nucl Med; 2021 Mar; 35(3):299-306. PubMed ID: 33387281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
    Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
    J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparison of
    Lee I; Kim JS; Park JY; Byun BH; Park SY; Choi JH; Moon H; Kim JY; Lee KC; Chi DY; Kim KM; Lim I; Kang JH; Ahn SH; Kim BI; Ha JH; Lim SM
    Synapse; 2018 Jul; 72(7):e22032. PubMed ID: 29486515
    [No Abstract]   [Full Text] [Related]  

  • 6. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages.
    Wang J; Zuo CT; Jiang YP; Guan YH; Chen ZP; Xiang JD; Yang LQ; Ding ZT; Wu JJ; Su HL
    J Neurol; 2007 Feb; 254(2):185-90. PubMed ID: 17334953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segmentation-based MR attenuation correction including bones also affects quantitation in brain studies: an initial result of 18F-FP-CIT PET/MR for patients with parkinsonism.
    Choi H; Cheon GJ; Kim HJ; Choi SH; Lee JS; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
    J Nucl Med; 2014 Oct; 55(10):1617-22. PubMed ID: 25134529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.
    Varrone A; Sansone V; Pellecchia MT; Amboni M; Salvatore E; De Michele G; Filla A; Barone P; Pappatà S; Salvatore M
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1343-9. PubMed ID: 18283454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.
    Kim JS; Cho H; Choi JY; Lee SH; Ryu YH; Lyoo CH; Lee MS
    PLoS One; 2015; 10(7):e0132585. PubMed ID: 26147749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.
    Eshuis SA; Jager PL; Maguire RP; Jonkman S; Dierckx RA; Leenders KL
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):454-62. PubMed ID: 19037637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification and discriminative power of
    Delva A; Van Weehaeghe D; van Aalst J; Ceccarini J; Koole M; Baete K; Nuyts J; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1913-1926. PubMed ID: 31776633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease.
    Eshuis SA; Maguire RP; Leenders KL; Jonkman S; Jager PL
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):200-9. PubMed ID: 16228235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uneven age effects of [(18)F]FP-CIT binding in the striatum of Parkinson's disease.
    Lee CS; Kim SJ; Oh SJ; Kim HO; Yun SC; Doudet D; Kim JS
    Ann Nucl Med; 2014 Nov; 28(9):874-9. PubMed ID: 25008292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using
    Cascianelli S; Tranfaglia C; Fravolini ML; Bianconi F; Minestrini M; Nuvoli S; Tambasco N; Dottorini ME; Palumbo B
    Hell J Nucl Med; 2017; 20 Suppl():165. PubMed ID: 29324935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal DAT changes measured with [
    Kerstens VS; Fazio P; Sundgren M; Brumberg J; Halldin C; Svenningsson P; Varrone A
    Neuroimage Clin; 2023; 37():103347. PubMed ID: 36822016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary Gland Uptake on
    Kang SY; Yun JY; Kang YK; Moon BS; Yoon HJ; Yoo MY; Kim BS
    Korean J Radiol; 2023 Jul; 24(7):690-697. PubMed ID: 37404111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of dopamine transporters in Parkinson disease: a meta-analysis of
    Kong Y; Zhang C; Liu K; Wagle Shukla A; Sun B; Guan Y
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1524-1534. PubMed ID: 32794655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.